Occupational exposure to benzene in South Korea. 2005

Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
Occupational Safety and Health Research Institute (OSHRI), Korea Occupational Safety and Health agency (KOSHA), 34-4 Gusan-dong, Bupyeong-gu, Incheon 403-711, Republic of Korea. skk@kosha.net

Benzene has been used in various industries as glues or solvents in Korea. Since 1981, a preparation containing more than 1% benzene is not allowed to be manufactured, used or dealt with in the workplace, except in laboratories and in those situations benzene must be used in a completely sealed process as specified in Industrial Safety and Health Act (ISHA). Claims for compensation of hematopoietic diseases related to benzene have been rising even though the work environment has been improved. This study was conducted to assess the status of benzene exposure in different industries in Korea. We reviewed the claimed cases investigated by the Korea Occupational Safety and Health Agency (KOSHA) between 1992 and 2000. The Survey of National Work Environment Status in 1998 was analyzed to assume the number of workers and factories exposed to benzene. In 2000, six factories were investigated to evaluate benzene exposure. Personal air monitoring was performed in 61 workers and urine samples were collected from 57 workers to measure trans,trans-muconic acid (t,t-MA). Hematologic examination has performed. Thirty-four cases of hematopoietic diseases were investigated by KOSHA including eight cases of myelodysplastic syndrome and eight cases of acute myelocytic leukemia. Eight cases were accepted as related to benzene exposure. The number of workers possibly exposed to benzene can be estimated to be 196,182 workers from 6219 factories based on the database. The geometric mean of benzene in air was 0.094 (0.005-5.311) ppm. Seven samples were higher than 1 ppm but they did not go over the 10 ppm occupational exposure limit (OEL) value in Korea. The geometric mean of trans,trans-muconic acid in urine was 0.966 (0.24-2.74) mg/g creatinine. The benzene exposure level was low except in a factory where benzene was used to polymerize other chemicals. The ambient benzene from 0.1 to 1 ppm was significantly correlated with urine t,t-MA concentration (r=0.733, p<0.01). Hematologic parameters did not show significant difference among groups divided into the level of exposure. Korean workers were not highly exposed to benzene and the level of exposure was mostly less than 1 ppm. However, there might be an excessive risk of hematopoietic disorders due to relatively high past exposure. The OEL value of benzene was amended to 1 ppm from 10 ppm in 2002 and was effective since July 2003.

UI MeSH Term Description Entries
D007221 Industry Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries. Tertiary Sector,Industries,Sector, Tertiary,Sectors, Tertiary,Tertiary Sectors
D007723 Korea Former kingdom, located on Korea Peninsula between Sea of Japan and Yellow Sea on east coast of Asia. In 1948, the kingdom ceased and two independent countries were formed, divided by the 38th parallel.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D004784 Environmental Monitoring The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment. Monitoring, Environmental,Environmental Surveillance,Surveillance, Environmental
D005260 Female Females
D006403 Hematologic Tests Tests used in the analysis of the hemic system. Blood Tests,Hematologic Test,Hematological Tests,Test, Hematologic,Tests, Hematologic,Blood Test,Hematological Test,Test, Blood,Test, Hematological,Tests, Blood,Tests, Hematological

Related Publications

Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
March 1987, British journal of industrial medicine,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
January 1985, American journal of industrial medicine,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
June 1980, Haematologica,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
July 2023, Industrial health,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
January 2002, Occupational medicine (Philadelphia, Pa.),
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
July 2017, Infection control and hospital epidemiology,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
December 2016, Cadernos de saude publica,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
May 2005, Chemico-biological interactions,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
January 1987, American journal of industrial medicine,
Seong-Kyu Kang, and Mi-Young Lee, and Tae-Kyun Kim, and Jeong-Oh Lee, and Yeon Soon Ahn
September 1977, New Istanbul contribution to clinical science,
Copied contents to your clipboard!